HIGHLIGHT THERAPEUTICS
Highlight Therapeutics is a private, clinical-stage company dedicated to unlocking the full potential of immuno-oncology.
HIGHLIGHT THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care Medical
Founded:
2010-01-01
Address:
Paterna, Comunidad Valenciana, Spain
Country:
Spain
Website Url:
http://www.highlighttherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
34 961 10 99 55
Email Addresses:
[email protected]
Total Funding:
27.05 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Organization Schema
Similar Organizations
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Akashi Therapeutics
Akashi Therapeutics is a clinical stage biopharmaceutical company.
GENFIT
GENFIT is a late-stage biopharmaceutical company.
Hope Medicine
Hope Medicine is a science-driven clinical stage biopharmaceutical company
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
MediPrint Ophthalmics
MediPrint Ophthalmics is a clinical stage eye care pharmaceutical company.
Mereo Biopharma
Mereo is a new UK-based speciality biopharmaceutical company.
Minerva Neuroscience
Minerva Neurosciences is a clinical-stage biopharmaceutical company
Molecular Partners
Molecular Partners is a clinical-stage biopharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
Touchlight Genetics
Touchlight Genetics, a British bio-pharmaceutical company founded in 2007.
Current Advisors List
Current Employees Featured
Founder
Investors List
Centre for the Development of Industrial Technology (CDTI)
Centre for the Development of Industrial Technology (CDTI) investment in Venture Round - Highlight Therapeutics
Advent Life Sciences
Advent Life Sciences investment in Venture Round - Highlight Therapeutics
Columbus Venture Partners
Columbus Venture Partners investment in Venture Round - Highlight Therapeutics
Realiza Business Angels
Realiza Business Angels investment in Venture Round - Highlight Therapeutics
Realiza Business Angels
Realiza Business Angels investment in Venture Round - Highlight Therapeutics
Official Site Inspections
http://www.highlighttherapeutics.com Semrush global rank: 7.79 M Semrush visits lastest month: 437
- Host name: 35.0.153.160.host.secureserver.net
- IP address: 160.153.0.35
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Highlight Therapeutics"
Home - Highlight Therapeutics
Highlight Therapeutics' R&D focuses on RNA-based therapy. Our lead candidate, BO-112, triggers a potent immune response, transforming "cold" tumors into "hot" ones, making them …See details»
Company - Highlight Therapeutics
It received a grant of more than €600,000 in 2016 from Spain’s Centre for the Development of Industrial Technology (CDTI) to support pre-clinical and clinical research into BO-112.See details»
Highlight Therapeutics - Crunchbase Company Profile & Funding
Organization. Highlight Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Contact Email …See details»
Highlight Therapeutics SL - LinkedIn
Highlight Therapeutics SL | 2,755 followers on LinkedIn. Unlocking the potential of immuno-oncology | Highlight, formerly known as Bioncotech Therapeutics S.L, is a private, clinical …See details»
Contact - Highlight Therapeutics
Highlight Therapeutics, S.L. Parque Científico Universidad de Valencia Calle Catedrático Agustín Escardino, 9 Paterna 46980 (Valencia) Spain.See details»
Highlight Therapeutics is a clinical-stage biopharmaceutical …
Highlight Therapeutics. About: Highlight Therapeutics is a clinical-stage biopharmaceutical company. Website: https://www.highlighttherapeutics.com/ Top Investors ...See details»
Highlight Therapeutics - Craft
Highlight Therapeutics (formerly Bioncotech) is a clinical-stage immune-oncology company. It develops RNA-based therapies against validated targets in cancer and immune cells.See details»
Highlight Therapeutics SL Information - RocketReach
Highlight, formerly known as Bioncotech Therapeutics S.L, is a private, clinical-stage company dedicated to unlocking the full potential of immuno-oncology.See details»
Highlight Therapeutics - 2025 Company Profile - Tracxn
4 days ago Highlight Therapeutics has raised a total funding of $27.1M over 2 rounds. Its first funding round was on Jan 01, 2015. Its latest funding round was a Series B round on Feb 05, …See details»
Highlight Therapeutics - PitchBook
Highlight Therapeutics General Information Description. Developer of RNA-based immuno-oncology therapies designed to combat cancer in patients. The company's therapies …See details»
HIGHLIGHT THERAPEUTICS - PCUV
Esta empresa se dedica al desarrollo de nuevos fármacos en el campo de la inmuno-oncología que se encuentra en etapa clínica. Hightlight Therapeutics está financiada por un Capital …See details»
Highlight Therapeutics SL Company Overview, Contact Details ...
Feb 4, 2021 Highlighttherapeutics hired Carlos Paya as Executive Chairman on Apr 17th '20. April 17, 2020: Highlight Therapeutics (“Highlight”), a clinical-stagebio pharmaceutical …See details»
Highlight Therapeutics | Advent Life Sciences
Highlight Therapeutics S. L. [email protected] Marisol Quintero, CEO. Mo PR Advisory Tel: +44 (0) 7876 444977 / 07860 361746 Mo Noonan/Jonathan Birt. Notes to …See details»
Highlight Therapeutics announces name change from
MADRID, Spain, April 17, 2020 (GLOBE NEWSWIRE) -- Highlight Therapeutics, a clinical-stage biopharmaceutical company developing RNA-based therapies...See details»
Highlight Therapeutics - Company Information, Competitors, …
Find useful insights on Highlight Therapeutics's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Highlight …See details»
Investors - Highlight Therapeutics
Highlight Therapeutics, S.L. Parque Científico Universidad de Valencia Calle Catedrático Agustín Escardino, 9 Paterna 46980 (Valencia) Spain.See details»
Quibim partners with Highlight Therapeutics to advance …
Mar 30, 2021 Global incidence of melanoma has reached epidemic proportions and cases are expected to grow to almost half a million by 2040, according to the World Health Organization. …See details»
Pipeline - Highlight Therapeutics
A Multicenter, Open-label, Non-randomized, Clinical Trial to Evaluate Safety, Tolerability and Preliminary Efficacy of Intra-lesional BO-112 in Patients With Resectable Primary Low and …See details»
Highlight Therapeutics: BO-112 published in JITC - GlobeNewswire
Dec 2, 2021 Highlight Therapeutics S. L. [email protected]: Marisol Quintero, CEO Mo PR Advisory: Tel: +44 (0) 7876 444977 / 07860 361746: Mo Noonan/Jonathan BirtSee details»
R&I - Highlight Therapeutics
Our lead drug candidate BO-112 is a best-in-class RNA-based therapy which has been demonstrated to initiate a powerful immune response, leveraging a unique multi-target …See details»